Stoked Bio: Funding, Investors & Team (Sep 2026)
Stoked Bio is a biotechnology company focused on discovering and developing new therapeutics for drug-resistant diseases, particularly infections and cancers. It applies a biology-first, AI-guided approach that integrates proprietary datasets and machine learning to identify and design novel small-molecule drug candidates with measurable biological effects. The company’s work emphasizes overcoming limitations of traditional drug discovery by accelerating the identification and synthesis of compounds that can address resistance and unmet clinical needs. Its research pipeline includes therapeutics targeting bacterial, fungal, and viral infections as well as oncology indications, with candidates progressing through preclinical development. Stoked Bio also advances specific programs such as novel antibiotics discovered through AI-assisted methods, aiming to improve treatment options while reducing development time and cost.
Stoked Bio has raised $370k across 1 funding round on record, the most recent an undisclosed round of $370k announced in May 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Stoked Bio Company Profile and Key Stats
Latest funding round on record: May 2026.
Stoked Bio Funding Rounds
Stoked Bio Founders and Leadership Team
Contact details for the Stoked Bio team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Stoked Bio Funding Compared to Other Biotechnology Startups
Stoked Bio's latest round of $370k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Stoked Bio in Biotechnology and Hamilton
Companies Similar to Stoked Bio
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ZYUS is a biopharmaceutical company focused on providing patients with cannabinoids and other plant-based…
Stoked Bio Funding FAQs
What does Stoked Bio do?
Stoked Bio is a biotechnology company focused on discovering and developing new therapeutics for drug-resistant diseases, particularly infections and cancers. It applies a biology-first, AI-guided approach that integrates proprietary datasets and machine learning to identify and design novel small-molecule drug candidates with measurable biological effects. The company’s work emphasizes overcoming limitations of traditional drug discovery by accelerating the identification and synthesis of compounds that can address resistance and unmet clinical needs. Its research pipeline includes therapeutics targeting bacterial, fungal, and viral infections as well as oncology indications, with candidates progressing through preclinical development. Stoked Bio also advances specific programs such as novel antibiotics discovered through AI-assisted methods, aiming to improve treatment options while reducing development time and cost.
How much funding has Stoked Bio raised?
Stoked Bio has raised $370k across 1 round on record. The most recent is an undisclosed round of $370k announced in May 2026.
When did Stoked Bio last raise funding?
Stoked Bio's most recent funding round on record is an undisclosed round of $370k, announced in May 2026.
Who founded Stoked Bio?
FundedIQ lists Jeff Skinner (Founder) at Stoked Bio.
Where is Stoked Bio headquartered?
Stoked Bio is based in Hamilton, Ontario, Canada.
How many employees does Stoked Bio have?
Stoked Bio is in the 1-10 employee band.
How does Stoked Bio's funding compare to other Biotechnology startups?
Stoked Bio's latest round of $370k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Stoked Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Stoked Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.